Company / Book Value per Share
Dianthus Therapeutics, Inc. /DE/ Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$15.857
FY2025
5-year range
-$50.751 / $32.769
FY2021-FY2025
Trend
+39.1%
vs FY2024
Sector context
#38 of 209
Health Care
What the data says
Dianthus Therapeutics, Inc. /DE/'s book value per share of $15.857 is higher than 82% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from -$59.392 in FY2016 to $61.945 in FY2018.
Based on SEC 10-K filings.
$15.857 in FY2025 with a 5-year CAGR of +37.1%. Top quartile in the Health Care sector.
Declined from $32.769 to $15.857 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +37.1%
- 10-Year CAGR
- -
Sector benchmark
-92.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +37.1%, indicating consistent growth.
- In FY2025, book value per share increased 39.1% year-over-year.
- Ranks #38 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.857 | +39.1% |
| FY2024 | $11.397 | -65.2% |
| FY2023 | $32.769 | +164.6% |
| FY2022 | -$50.751 | -16067.3% |
| FY2021 | -$0.314 | -109.6% |
| FY2020 | $3.277 | -22.7% |
| FY2019 | $4.239 | -93.2% |
| FY2018 | $61.945 | +373.1% |
| FY2017 | -$22.682 | +61.8% |
| FY2016 | -$59.392 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026